Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele

M. Meznaric, L. Gonzalez-Quereda, E. Gallardo, N. de Luna, P. Gallano, M. Fanin, C. Angelini, B. Peterlin, J. Zidar

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: In some cases, a definitive confirmation of dysferlinopathy cannot be achieved by DNA test, because the mutation is detected in one allele only. Patients and methods: Dysferlin expression in skeletal muscle and peripheral blood monocytes (PBM) was studied by Western blot in two unrelated adult patients. The comparative CT method (ΔΔCT) was used to calculate relative changes in dysferlin mRNA determined from real-time quantitative PCR experiments. The dysferlin gene was studied by direct sequencing of cDNA and genomic DNA and by Multiplex Ligation-dependent Probe Amplification (MLPA) analysis. Results: A comparable severe reduction in dysferlin was demonstrated in both skeletal muscle and PBM. The expression of dysferlin mRNA was significantly reduced. A novel mutation in exon 47 (c.5289G>C) of the dysferlin gene in the heterozygous state, causing an amino acid change (p.Glu1763Asp), was detected in both patients. The MLPA analysis did not reveal any deletion or duplication. Conclusions: Dysferlin and/or dysferlin mRNA abnormalities are diagnostic for dysferlinopathy when mutational analysis detects a mutation in one allele only. Analysis of dysferlin mRNA can be helpful for distinguishing symptomatic heterozygotes from such patients.

Original languageEnglish
Pages (from-to)1021-1023
Number of pages3
JournalEuropean Journal of Neurology
Volume18
Issue number7
DOIs
Publication statusPublished - Jul 2011

Fingerprint

Monocytes
Skeletal Muscle
Alleles
Messenger RNA
Multiplex Polymerase Chain Reaction
Mutation
DNA
Heterozygote
Genes
Real-Time Polymerase Chain Reaction
Exons
Complementary DNA
Western Blotting
Amino Acids
Dysferlinopathy

Keywords

  • Dysferlin mRNA
  • Dysferlinopathy
  • Heterozygous state
  • Miyoshi myopathy

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele. / Meznaric, M.; Gonzalez-Quereda, L.; Gallardo, E.; de Luna, N.; Gallano, P.; Fanin, M.; Angelini, C.; Peterlin, B.; Zidar, J.

In: European Journal of Neurology, Vol. 18, No. 7, 07.2011, p. 1021-1023.

Research output: Contribution to journalArticle

Meznaric, M, Gonzalez-Quereda, L, Gallardo, E, de Luna, N, Gallano, P, Fanin, M, Angelini, C, Peterlin, B & Zidar, J 2011, 'Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele', European Journal of Neurology, vol. 18, no. 7, pp. 1021-1023. https://doi.org/10.1111/j.1468-1331.2010.03240.x
Meznaric, M. ; Gonzalez-Quereda, L. ; Gallardo, E. ; de Luna, N. ; Gallano, P. ; Fanin, M. ; Angelini, C. ; Peterlin, B. ; Zidar, J. / Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele. In: European Journal of Neurology. 2011 ; Vol. 18, No. 7. pp. 1021-1023.
@article{1aaa5173cf3d4f088885d912572745d4,
title = "Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele",
abstract = "Background: In some cases, a definitive confirmation of dysferlinopathy cannot be achieved by DNA test, because the mutation is detected in one allele only. Patients and methods: Dysferlin expression in skeletal muscle and peripheral blood monocytes (PBM) was studied by Western blot in two unrelated adult patients. The comparative CT method (ΔΔCT) was used to calculate relative changes in dysferlin mRNA determined from real-time quantitative PCR experiments. The dysferlin gene was studied by direct sequencing of cDNA and genomic DNA and by Multiplex Ligation-dependent Probe Amplification (MLPA) analysis. Results: A comparable severe reduction in dysferlin was demonstrated in both skeletal muscle and PBM. The expression of dysferlin mRNA was significantly reduced. A novel mutation in exon 47 (c.5289G>C) of the dysferlin gene in the heterozygous state, causing an amino acid change (p.Glu1763Asp), was detected in both patients. The MLPA analysis did not reveal any deletion or duplication. Conclusions: Dysferlin and/or dysferlin mRNA abnormalities are diagnostic for dysferlinopathy when mutational analysis detects a mutation in one allele only. Analysis of dysferlin mRNA can be helpful for distinguishing symptomatic heterozygotes from such patients.",
keywords = "Dysferlin mRNA, Dysferlinopathy, Heterozygous state, Miyoshi myopathy",
author = "M. Meznaric and L. Gonzalez-Quereda and E. Gallardo and {de Luna}, N. and P. Gallano and M. Fanin and C. Angelini and B. Peterlin and J. Zidar",
year = "2011",
month = "7",
doi = "10.1111/j.1468-1331.2010.03240.x",
language = "English",
volume = "18",
pages = "1021--1023",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "7",

}

TY - JOUR

T1 - Abnormal expression of dysferlin in skeletal muscle and monocytes supports primary dysferlinopathy in patients with one mutated allele

AU - Meznaric, M.

AU - Gonzalez-Quereda, L.

AU - Gallardo, E.

AU - de Luna, N.

AU - Gallano, P.

AU - Fanin, M.

AU - Angelini, C.

AU - Peterlin, B.

AU - Zidar, J.

PY - 2011/7

Y1 - 2011/7

N2 - Background: In some cases, a definitive confirmation of dysferlinopathy cannot be achieved by DNA test, because the mutation is detected in one allele only. Patients and methods: Dysferlin expression in skeletal muscle and peripheral blood monocytes (PBM) was studied by Western blot in two unrelated adult patients. The comparative CT method (ΔΔCT) was used to calculate relative changes in dysferlin mRNA determined from real-time quantitative PCR experiments. The dysferlin gene was studied by direct sequencing of cDNA and genomic DNA and by Multiplex Ligation-dependent Probe Amplification (MLPA) analysis. Results: A comparable severe reduction in dysferlin was demonstrated in both skeletal muscle and PBM. The expression of dysferlin mRNA was significantly reduced. A novel mutation in exon 47 (c.5289G>C) of the dysferlin gene in the heterozygous state, causing an amino acid change (p.Glu1763Asp), was detected in both patients. The MLPA analysis did not reveal any deletion or duplication. Conclusions: Dysferlin and/or dysferlin mRNA abnormalities are diagnostic for dysferlinopathy when mutational analysis detects a mutation in one allele only. Analysis of dysferlin mRNA can be helpful for distinguishing symptomatic heterozygotes from such patients.

AB - Background: In some cases, a definitive confirmation of dysferlinopathy cannot be achieved by DNA test, because the mutation is detected in one allele only. Patients and methods: Dysferlin expression in skeletal muscle and peripheral blood monocytes (PBM) was studied by Western blot in two unrelated adult patients. The comparative CT method (ΔΔCT) was used to calculate relative changes in dysferlin mRNA determined from real-time quantitative PCR experiments. The dysferlin gene was studied by direct sequencing of cDNA and genomic DNA and by Multiplex Ligation-dependent Probe Amplification (MLPA) analysis. Results: A comparable severe reduction in dysferlin was demonstrated in both skeletal muscle and PBM. The expression of dysferlin mRNA was significantly reduced. A novel mutation in exon 47 (c.5289G>C) of the dysferlin gene in the heterozygous state, causing an amino acid change (p.Glu1763Asp), was detected in both patients. The MLPA analysis did not reveal any deletion or duplication. Conclusions: Dysferlin and/or dysferlin mRNA abnormalities are diagnostic for dysferlinopathy when mutational analysis detects a mutation in one allele only. Analysis of dysferlin mRNA can be helpful for distinguishing symptomatic heterozygotes from such patients.

KW - Dysferlin mRNA

KW - Dysferlinopathy

KW - Heterozygous state

KW - Miyoshi myopathy

UR - http://www.scopus.com/inward/record.url?scp=79958853163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958853163&partnerID=8YFLogxK

U2 - 10.1111/j.1468-1331.2010.03240.x

DO - 10.1111/j.1468-1331.2010.03240.x

M3 - Article

C2 - 21658164

AN - SCOPUS:79958853163

VL - 18

SP - 1021

EP - 1023

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 7

ER -